Cart
sales@molnova.com
WZ811
CAS No. 55778-02-4
WZ811( WZ811 | WZ-811 | WZ 811 )
Catalog No. M15027 CAS No. 55778-02-4
WZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | In Stock |
|
| 10MG | 55 | In Stock |
|
| 25MG | 104 | In Stock |
|
| 50MG | 167 | In Stock |
|
| 100MG | 233 | In Stock |
|
| 200MG | 302 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWZ811
-
NoteResearch use only, not for human use.
-
Brief DescriptionWZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
-
DescriptionWZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsWZ811 | WZ-811 | WZ 811
-
PathwayAutophagy
-
TargetCXCR
-
RecptorCXCR4
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number55778-02-4
-
Formula Weight290.36
-
Molecular FormulaC18H18N4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 30 mg/mL (103.32 mM)
-
SMILESC1(CNC2=NC=CC=C2)=CC=C(CNC3=NC=CC=C3)C=C1
-
Chemical NameN,N'-(1,4-phenylenebis(methylene))bis(pyridin-2-amine)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhan W, et al. J Med Chem, 2007, 50(23), 5655-5664.
molnova catalog
related products
-
Ulocuplumab
Ulocuplumab (BMS-936564) is a fully human anti-CXCR4 IgG4 antibody.Ulocplumab exhibits antitumor activity in acute myeloid leukemia (AML), non-Hodgkin's lymphoma (NHL), and multiple myeloma transplantation models.
-
MSX-130
MSX-130 is CXCR4 Antagonist.
-
Eldelumab
Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10. It has anti-inflammatory properties, selectively binds to CXCL10, and can be used in the study of rheumatoid arthritis, ulcerative colitis, and Crohn's disease.
